Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZC28
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,835
Award facts
- Contract value 100% obligated
- $14,834.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $14.8K by the Defense Logistics Agency on June 20, 2025, for the supply of Entyvio 300 mg vials. This delivery order operates under a firm fixed-price contract structure with an ultimate completion date of July 14, 2025, and carries no set-aside designation. The award represents a task order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's SPE2DB program, a $500M vehicle that enables the agency to procure pharmaceutical products and medical supplies supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure consistent contracts with the Department of Defense. The company's portfolio includes an extensive range of pharmaceutical products spanning branded and generic prescription medications, biologics, vaccines, and specialty items such as oncology treatments and auto-injectors. Entyvio, a gastrointestinal therapeutic product, aligns with the company's demonstrated capability in supplying specialty pharmaceuticals to military and federal healthcare systems across the nation. The firm's longstanding registration in the System for Award Management since 2001 and robust history of contract performance underscore its established position as a dependable federal pharmaceutical distributor.
Quick answers
Who was awarded contract SPE2DB25FZC28?
SPE2DB25FZC28 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 20, 2025.
How much is contract SPE2DB25FZC28 worth?
The government has obligated $14,835 on SPE2DB25FZC28.
Is contract SPE2DB25FZC28 an order under another contract?
Yes. SPE2DB25FZC28 is a delivery order under SPE2DB22D9143, an indefinite delivery contract.
Was contract SPE2DB25FZC28 competed?
The extent of competition for SPE2DB25FZC28 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award